Related Experiment Video
Updated: Aug 6, 2025

Using Optical Coherence Tomography and Optokinetic Response As Structural and Functional Visual System Readouts in Mice and Rats
Published on: January 10, 2019
Severity of cystoid macular oedema in preterm infants observed using hand-held spectral domain optical coherence
Samira Anwar1,2, Mintu Nath3, Irene Gottlob4
1Department of Ophthalmology, University Hospitals of Leicester NHS Trust, Leicester, UK. sa897@leicester.ac.uk.
Insights
Cystoid macular oedema (CMO) in preterm infants, measured by handheld spectral domain optical coherence tomography (HH-SD-OCT), shows improved severity weekly for both fovea and dome types. No association was found with retinopathy of prematurity (ROP).
Area of Science:
- Ophthalmology
- Neonatology
- Medical Imaging
Background:
- Cystoid macular oedema (CMO) is a concern in preterm infants.
- Handheld spectral domain optical coherence tomography (HH-SD-OCT) is a key tool for assessing infant retinal health.
- Understanding CMO's relationship with gestational age and other factors is crucial for preterm infant eye care.
Purpose of the Study:
- To investigate the relationship between cystoid macular oedema (CMO) in preterm infants and factors like gestational age at birth (GA), birthweight (BW), retinopathy of prematurity (ROP), and external limiting membrane (ELM) status.
- To quantify CMO using HH-SD-OCT, differentiating between 'fovea' and 'dome' types.
- To analyze the changes in CMO severity over postmenstrual age (PMA).
Main Methods:
- A prospective observational study involving 112 preterm infants (23-36 weeks GA).
- Retinal imaging was performed using HH-SD-OCT between 31 to 44 weeks PMA.
- CMO was measured for thickness, width, area, and peak, categorized as 'fovea' or 'dome'.
Main Results:
- CMO was detected in 22.9% of preterm infants and 19.2% of images.
- 'Dome' CMO was significantly larger in thickness, area, and peak compared to 'fovea' CMO (P < 0.0001).
- CMO area and width decreased significantly with increasing PMA for both types, indicating improvement over time.
Conclusions:
- HH-SD-OCT imaging in preterm infants reveals a weekly improvement in CMO severity for both 'fovea' and 'dome' types.
- The study found no association between the presence of ROP and CMO detection or CMO with an absent ELM.
- CMO severity, as measured by HH-SD-OCT, demonstrates a positive trend of resolution in preterm infants.
Objective:
To investigate the relationship between cystoid macular oedema (CMO) measured in preterm infants using hand-held spectral domain optical coherence tomography (HH SD-OCT), with gestational age at birth (GA), birthweight (BW), diagnosis of retinopathy of prematurity (ROP) and the presence or absence of the external limiting membrane (ELM).
Methods:
We conducted a prospective mixed cross-sectional/longitudinal observational study of 112 participants (23 to 36 weeks GA; n = 25 with, and n = 87 without, CMO). Retinal images were acquired using 344 HH SD-OCT (n = 66 with and n = 278 without, CMO) between 31 to 44 weeks postmenstrual age (PMA). CMO type ('fovea' and 'dome') was measured using thickness, width, area and peak.
Results:
CMO was observed in 22.9% of preterm infants, and 19.2% of images. The mean values for thickness, width, area and peak of 'dome' CMO were 128.47 µm (SD +/- 34.23), 3624.45 µm (SD +/- 1323.03), 0.49 mm2 (SD +/- 0.28) and 279.81 µm (SD +/- 13.57) respectively. The mean values for thickness, width, area and peak of 'fovea' CMO were 64.37 µm (SD +/- 17.11), 2226.28 µm (SD +/- 1123.82), 0.16 mm2 (SD +/- 0.11) and 95.03 µm (SD +/- 26.99) respectively. Thickness, area width and peak were significantly greater for 'dome CMO compared with 'fovea' CMO (P < 0.0001 for thickness, area and peak; P < 0.01 for width). Area and width significantly decreased with PMA for 'dome' and 'fovea' CMO (p = 0.0028; p < 0.001 respectively). No association was found between the presence of ROP and the detection of CMO or detection of CMO with absence of ELM.
Conclusions:
HH -OCT in preterm infants demonstrates that the severity of CMO appearance improves each week for both fovea and dome CMO.
More Related Videos
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment

